What does DR. CUYKX do?

DR. CUYKX is a hospital in Wommelgem. Private Limited, started on 25 March 2004, 1 establishment.

What is the address of DR. CUYKX?

The registered office of DR. CUYKX is located at Cruyenveldebaan 50, 2160 Wommelgem.

Is DR. CUYKX still active?

Yes. According to the CBE (30 September 2026) DR. CUYKX is active, legal situation “Normale toestand”, started on 25 March 2004.

Is DR. CUYKX registered on Peppol?

Yes, DR. CUYKX is registered on the Peppol network with ID 0208:0864309491.

What is the enterprise number of DR. CUYKX?

The enterprise number of DR. CUYKX is BE0864309491.

When was DR. CUYKX founded?

DR. CUYKX was founded on 25 March 2004.

Who are the directors of DR. CUYKX?

According to the 2025 annual accounts, the directors of DR. CUYKX are: Hans Cuykx.

Is DR. CUYKX a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 25 March 2004; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did DR. CUYKX make in 2025?

DR. CUYKX posted a profit after taxes of € 202,144 in financial year 2025.

What is the revenue of DR. CUYKX?

As a small company, DR. CUYKX is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 307,041.

DR. CUYKX (Private Limited) - Wommelgem - BE0864309491

Dossier DR. CUYKX, printed on 30 September 2026 from databakkes.be/en/0864309491/dr-cuykx. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 3 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

DR. CUYKX from Wommelgem, company number BE0864309491, closed financial year 2025 with a result of € 202,144 after tax. For that financial year DR. CUYKX recorded a gross margin of € 307,041 and equity of € 772,282. Compared with financial year 2024, the result moved from € 183,990 to € 202,144. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on April 22, 2026.

What it is worth Healthy

€ 772,282

▼ 12% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 202,144

▲ 10% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 13,400

▼ 53% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 310,000 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Vehicles and equipment

€ 625

▼ 48% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 1 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 88,920

▲ 65% vs 2024

€ 66,416 is repaid this year. At this pace the long-term loan is gone in ≈ 1 years.

Owed to suppliers

€ 2,960

▼ 85% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 85,770

▲ 23% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 199,196 Gross margin 2022: € 199,196 First fiscal year in the series	€ 254,000 Gross margin 2023: € 254,000 ▲ 28% vs 2022 (€ 199,196) Favourable step	€ 279,584 Gross margin 2024: € 279,584 ▲ 10% vs 2023 (€ 254,000) Favourable step	€ 307,041 Gross margin 2025: € 307,041 ▲ 10% vs 2024 (€ 279,584) Favourable step	▲ 10%
Profit after taxes	€ 123,197 Profit after taxes 2022: € 123,197 First fiscal year in the series	€ 158,560 Profit after taxes 2023: € 158,560 ▲ 29% vs 2022 (€ 123,197) Favourable step	€ 183,990 Profit after taxes 2024: € 183,990 ▲ 16% vs 2023 (€ 158,560) Favourable step	€ 202,144 Profit after taxes 2025: € 202,144 ▲ 10% vs 2024 (€ 183,990) Favourable step	▲ 10%
Equity	€ 976,089 Equity 2022: € 976,089 First fiscal year in the series	€ 848,148 Equity 2023: € 848,148 ▼ 13% vs 2022 (€ 976,089) Unfavourable step	€ 880,138 Equity 2024: € 880,138 ▲ 4% vs 2023 (€ 848,148) Favourable step	€ 772,282 Equity 2025: € 772,282 ▼ 12% vs 2024 (€ 880,138) Unfavourable step	▼ 12%
Total debts	€ 160,863 Total debts 2022: € 160,863 First fiscal year in the series	€ 398,590 Total debts 2023: € 398,590 ▲ 148% vs 2022 (€ 160,863) Unfavourable step	€ 301,715 Total debts 2024: € 301,715 ▼ 24% vs 2023 (€ 398,590) Favourable step	€ 488,648 Total debts 2025: € 488,648 ▲ 62% vs 2024 (€ 301,715) Unfavourable step	▲ 62%
Cash	€ 19,672 Cash 2022: € 19,672 First fiscal year in the series	€ 33,452 Cash 2023: € 33,452 ▲ 70% vs 2022 (€ 19,672) Favourable step	€ 28,435 Cash 2024: € 28,435 ▼ 15% vs 2023 (€ 33,452) Unfavourable step	€ 13,400 Cash 2025: € 13,400 ▼ 53% vs 2024 (€ 28,435) Unfavourable step	▼ 53%
Retained profit	€ 976,089 Retained profit 2022: € 976,089 First fiscal year in the series	€ 848,148 Retained profit 2023: € 848,148 ▼ 13% vs 2022 (€ 976,089) Unfavourable step	€ 880,138 Retained profit 2024: € 880,138 ▲ 4% vs 2023 (€ 848,148) Favourable step	€ 772,282 Retained profit 2025: € 772,282 ▼ 12% vs 2024 (€ 880,138) Unfavourable step	▼ 12%
Dividend	€ 16,620 Dividend 2022: € 16,620 First fiscal year in the series	€ 286,500 Dividend 2023: € 286,500 ▲ € 269,880 vs 2022 (€ 16,620) Unchanged	€ 152,000 Dividend 2024: € 152,000 ▼ 47% vs 2023 (€ 286,500) Unchanged	€ 310,000 Dividend 2025: € 310,000 ▲ 104% vs 2024 (€ 152,000) Unchanged	▲ 104%
Bank debt	€ 89,405 Bank debt 2022: € 89,405 First fiscal year in the series	€ 55,484 Bank debt 2023: € 55,484 ▼ 38% vs 2022 (€ 89,405) Favourable step	€ 53,817 Bank debt 2024: € 53,817 ▼ 3% vs 2023 (€ 55,484) Favourable step	€ 88,920 Bank debt 2025: € 88,920 ▲ 65% vs 2024 (€ 53,817) Unfavourable step	▲ 65%
Balance sheet total	€ 1,136,952 Balance sheet total 2022: € 1,136,952 First fiscal year in the series	€ 1,246,738 Balance sheet total 2023: € 1,246,738 ▲ 10% vs 2022 (€ 1,136,952) Unchanged	€ 1,181,853 Balance sheet total 2024: € 1,181,853 ▼ 5% vs 2023 (€ 1,246,738) Unchanged	€ 1,260,930 Balance sheet total 2025: € 1,260,930 ▲ 7% vs 2024 (€ 1,181,853) Unchanged	▲ 7%

Key figures of DR. CUYKX, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 April 2027.

What happened to DR. CUYKX?

What happened at DR. CUYKX in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Apr 22, 2026 New annual accounts for financial year 2025: profit of € 202,144 (▲ 10% vs 2024). Source: NBB ↗
Mar 25, 2004 New establishment in Turnhout. KBO
Mar 25, 2004 Start of the company according to the CBE. KBO
2004 Hans Cuykx became a director. NBB

In short

From € 123,197 profit in 2022 to € 202,144 profit in 2025.

Paid € 322,709 in corporate taxes since 2022.

Best year ever: 2025, with € 202,144 profit.

Paid out € 765,120 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at DR. CUYKX? We notify you, reason included.

Follow DR. CUYKX

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Hans Cuykx

DR. CUYKX

Behind DR. CUYKX is Hans Cuykx.

See the full network in the app

Directors

According to the 2025 annual accounts

Hans Cuykx

Director

since 2004

Establishments

Establishment units

Physical locations of this company

Registered office

Cruyenveldebaan 50

2160 Wommelgem

2.302.629.649

Rubensstraat 166

2300 Turnhout

Active since 25 March 2004

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0864.309.491
VAT number: BE 0864.309.491
Registered office: Cruyenveldebaan 50, 2160 Wommelgem
Names & denominations: DR. CUYKX
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 25 March 2004
Peppol: Active · Active since 24 Nov 2023
Activities · NACE: Overige hospitalisatiediensten

View on CBE Public ↗ Annual accounts (NBB) ↗